BeatIt-ASD for Autism Spectrum Disorder

N/A

Waitlist Available

Led By Vanessa H Bal, PhD

Research Sponsored by Rutgers, The State University of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 1 (initial assessment) to week 16 (outcome) to week 22 (follow-up)

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to adapt the BeatIt program for autistic adults, including those with intellectual disabilities. The program helps improve mood by getting participants involved in meaningful activities. Researchers will see if this adapted program can help reduce depression in this group. The Beatalk technique, which uses beatbox sounds and rhythms to improve speech, has been tested as a new method for adults with intellectual disabilities.

Eligible Conditions

Autism Spectrum Disorder
Depression
Autism

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 1 (initial assessment) to week 16 (outcome) to week 22 (follow-up)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 1 (initial assessment) to week 16 (outcome) to week 22 (follow-up)

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1 (initial assessment) to week 16 (outcome) to week 22 (follow-up) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in behavioral activation on Behavioral Activation for Depression Scale (BADS)

Change in distress on Anxiety Depression and Mood Scale (ADAMS)

Change in distress on Glasgow Depression Scale (GDS)

+5 more

Secondary study objectives

Change in adaptive behavior on Vineland Adaptive Behavior Scale, 3rd edition (VABS-3)

Change in quality of life on Shalock Quality of Life Questionnaire

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Intervention GroupExperimental Treatment1 Intervention

Participants, along with a support person, will complete 12 weekly sessions of the BeatIt-ASD intervention. The support person will complete an initial session before commencement of the 12 weekly sessions.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

BeatIt-ASD

2021

N/A

~20

Do I qualify?Apply below to find out